Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Corpay Inc. (CPAY-N) is an Atlanta-based company specializing in digital services aimed at facilitating travel expense payments both domestically and internationally, including operations in Brazil. Recently, the company has made significant strides by investing in a platform in Europe, which features cross-currency capabilities, thereby enhancing its geographical diversification. With a steady business model, Corpay is currently trading at a price-to-earnings ratio of 25x and boasts a strong return on equity of 31%. The analysts recommend setting a stop-loss at $240, while the target price suggests a potential upside of 17%, peaking around $416. However, the company currently offers a dividend yield of 0%, indicating a focus on growth rather than returns to shareholders.
Corpay Inc. is a American stock, trading under the symbol CPAY-N on the New York Stock Exchange (CPAY). It is usually referred to as NYSE:CPAY or CPAY-N
In the last year, there was no coverage of Corpay Inc. published on Stockchase.
Corpay Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Corpay Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Corpay Inc. published on Stockchase.
On 2025-04-29, Corpay Inc. (CPAY-N) stock closed at a price of $324.25.
This Atlanta based company provides digital services to companies to assist with payment of travel expenses in the US, internationally and in Brazil. The company just made a major investment into establishing a platform in Europe, including cross-currency capability. Overall a geographically diversified steady business model. It trades at 25x earnings and supports a healthy 31% ROE. We recommend setting a stop-loss at $240, looking to achieve $416 — upside potential of 17%. Yield 0%
(Analysts’ price target is $415.71)